Pediatrics Strabismus News

Patients with amblyopia who were treated with the CureSight eye-tracking system achieved greater improvement in visual acuity at week 16 vs. those treated with patching, according to a study published in American Journal of Ophthalmology.

Tom Lee was crushed. Having just flown home across 12 time zones returning from a volunteer trip to Armenia, he heard some very disturbing news.

The article “Case report: Amblyopic reversal in an adult” by Kumar and colleagues in the March 10, 2024, issue of Healio | OSN reports on a 49-year-old woman who “showed spontaneous improvement of visual acuity in the amblyopic eye following loss of vision in the contralateral sound eye.”

Those who read my Lindstrom’s Perspective regularly know that I have a special interest in demographics and medical economics. This time, I am going to share a few thoughts on the medical economics of managing the progressive myope.

Data published in July in JAMA Ophthalmology showed that 0.01% atropine drops safely curbed myopia progression in children with intermittent exotropia and myopia.

With recent developments in AI and technology, potential improvements in vision screening tests are being examined in ophthalmology.

Adolescents with myopia have up to a twofold increased risk of experiencing anxiety and mood disorders, and the odds for both conditions increase with myopia severity, according to a study.

Spending at least 15 minutes at a time outside appeared to lead to less myopic shift among elementary school students, according to data published in JAMA Network Open.

The FDA granted rare pediatric disease designation to ATSN-201, a gene therapy candidate for the treatment of X-linked retinoschisis, according to a press release from Atsena Therapeutics.